Krystal Biotech, Inc. KRYS Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s investment purchases?
- Krystal Biotech, Inc. (KRYS) reported investment purchases of $160.03M in Q1 2026.
- How has Krystal Biotech, Inc.'s investment purchases changed year-over-year?
- Krystal Biotech, Inc.'s investment purchases increased by 16.1% year-over-year, from $137.81M to $160.03M.
- What is the long-term trend for Krystal Biotech, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s investment purchases has grown at a 22.0% compound annual growth rate (CAGR), from $190.46M to $422.54M.
- What does investment purchases mean?
- Cash used to buy financial investments like bonds or securities.
- How do you interpret investment purchases?
- An increase indicates the company is deploying excess cash into interest-bearing assets rather than holding cash equivalents.
- How does investment purchases compare across companies?
- Standard practice for cash-rich biotech companies to manage liquidity and preserve capital.